Randall A. Scharlach, MD

“Excellent cancer care can only be delivered when the patient is seen as a whole person, rather than merely a diagnosis. I take pride in offering individualized care that is the best possible fit for each patient’s unique circumstances.”

In his free time, Dr. Scharlach enjoys studying philosophy of mind, with a particular interest in the intersection between consciousness and the physical sciences which inform us about the fundamental nature of reality. He also enjoys skateboarding and spending time with his children, friends, and family.


MD: UCLA School of Medicine, Los Angeles, CA
Residency: New Haven Hospital, Yale University, New Haven, CT (served as Chief Resident)

Board Certification

American Board of Radiology, Radiation Oncology
Dr. Scharlach is recognized as an expert in the most advanced radiotherapeutic technologies, including IMRT and IGRT as well as stereotactic radiation. Dr. Scharlach’s publications include research in endometrial cancer and a textbook chapter on salivary gland malignancies. He has presented well over fifty lectures for professional education on multiple topics including use of radioprotective drugs, the effects of hypoxia with radiation, oncology pain management, the use of cannabinoids in oncology and the development of advanced radiotherapy technologies. Dr. Scharlach’s areas of expertise include prostate, breast, lung and head/neck cancers.